Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    3334893 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Humanized LL2IGG to Treat Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: hLL2 (Epratuzumab)
2 Recruiting ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: ESHAP-Imatinib
3 Active, not recruiting Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
Conditions: Lymphoma, Non-Hodgkin;   Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Drug: Ifosfamide;   Drug: Mesna (IV);   Drug: Mesna (oral);   Drug: Carboplatin;   Drug: Etoposide;   Drug: Rituximab;   Other: PET Scan

Study has passed its completion date and status has not been verified in more than two years.